Archived Newsletters
-
10.12.26 -- Speeding Therapies To The Clinic
10/12/2026
10/12/26 Outsourced Pharma Newsletter
-
10.12.26 -- Remember Why You Are Outsourcing
10/12/2026
10/12/26 Outsourced Pharma Newsletter
-
10.10.26 -- Outsourced Pharma Newsletter - Best Of September
10/10/2026
10/10/26 Outsourced Pharma Newsletter
-
10.09.26 -- The Asset-Light Biotech Playbook: Outsource, Scale, Advance
10/9/2026
10/09/26 Outsourced Pharma Newsletter
-
10.08.26 -- The Case Of The Half Pill: AI As Outsourcing Detective
10/8/2026
10/08/26 Outsourced Pharma Newsletter
-
10.07.26 -- New Insights On Advancing AAV Development And Beyond
10/7/2026
10/07/26 Outsourced Pharma Newsletter
-
10.07.26 -- What's Driving The Next Wave Of Genome Editing?
10/7/2026
10/07/26 Outsourced Pharma Newsletter
-
10.07.26 -- What The Data Says About Europe's CDMO Advantage
10/7/2026
10/07/26 Outsourced Pharma Newsletter
-
10.06.26 -- Strategic CDMO Partnerships: From Vendor To Collaborative Partner
10/6/2026
10/06/26 Outsourced Pharma Newsletter
-
10.05.26 -- STREAM: GMP Strategy, AAV Analytics & Biologics Scale-Up
10/5/2026
10/05/26 Outsourced Pharma Newsletter